Mutations in the gene coding for alpha1-antitrypsin (A1AT) have long been a focus of chronic obstructive lung disease (COPD) research as a causative factor of early severe emphysema. The gene discussed is SERPINA1; the disease is chronic obstructive pulmonary disease.